171260 AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem

171260
Zobrazit ceny a dostupnost

Přehled

Replacement Information

Tabulka spec. kláve

Empirical FormulaCAS #
C₂₄H₂₅N₅O 866405-64-3

Ceny a dostupnost

Katalogové číslo DostupnostBalení ks/bal. Cena Množství
171260-10MG
Zjišťuji dostupnost...
Omezená dostupnostOmezená dostupnost
Na skladě 
Přerušeno
Dostupné omezené množství
Dostupnost bude potvrzena
    Remaining : Will advise
      Remaining : Will advise
      Bude poskytnuto
      Kontaktujte Zákaznický servis
      Contact Customer Service

      Plastová ampulka 10 mg
      Zjišťuji cenu...
      Cenu nelze zjistit
      Minimum Quantity needs to be mulitiple of
      S dokončenou objednávkou Další informace
      Ušetřili jste ()
       
      Vyžádat nacenění
      171260-1MG
      Zjišťuji dostupnost...
      Omezená dostupnostOmezená dostupnost
      Na skladě 
      Přerušeno
      Dostupné omezené množství
      Dostupnost bude potvrzena
        Remaining : Will advise
          Remaining : Will advise
          Bude poskytnuto
          Kontaktujte Zákaznický servis
          Contact Customer Service

          Plastová ampulka 1 mg
          Zjišťuji cenu...
          Cenu nelze zjistit
          Minimum Quantity needs to be mulitiple of
          S dokončenou objednávkou Další informace
          Ušetřili jste ()
           
          Vyžádat nacenění
          171260-5MG
          Zjišťuji dostupnost...
          Omezená dostupnostOmezená dostupnost
          Na skladě 
          Přerušeno
          Dostupné omezené množství
          Dostupnost bude potvrzena
            Remaining : Will advise
              Remaining : Will advise
              Bude poskytnuto
              Kontaktujte Zákaznický servis
              Contact Customer Service

              Plastová ampulka 5 mg
              Zjišťuji cenu...
              Cenu nelze zjistit
              Minimum Quantity needs to be mulitiple of
              S dokončenou objednávkou Další informace
              Ušetřili jste ()
               
              Vyžádat nacenění
              Description
              OverviewA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
              Catalogue Number171260
              Brand Family Calbiochem®
              Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
              References
              ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
              Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
              Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
              Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
              Inoki, K., et al. 2003. Cell 115, 577.
              Fryer, L.G., 2002. FEBS Lett. 531, 189.
              Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
              Product Information
              CAS number866405-64-3
              ATP CompetitiveY
              FormLight yellow solid
              Hill FormulaC₂₄H₂₅N₅O
              Chemical formulaC₂₄H₂₅N₅O
              ReversibleY
              Structure formula ImageStructure formula Image
              Quality LevelMQ100
              Applications
              Biological Information
              Primary TargetAMPK
              Primary Target IC<sub>50</sub>25.1, 148, and 234.6 nM, against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity, respectively
              Primary Target K<sub>i</sub>EC100 = 2.5 µM against BMP pathway-dependent dorsoventral development; EC50 = 5 µM against VEGF signaling-dependent intersomitic vessel formation in zebrafish embryo in vivo
              Purity≥95% by HPLC
              Physicochemical Information
              Cell permeableY
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
              Toxicity Standard Handling
              Storage +2°C to +8°C
              Protect from Light Protect from light
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
              Packaging Information
              Packaged under inert gas Packaged under inert gas
              Transport Information
              Supplemental Information
              Specifications

              Documentation

              AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem MSDS

              Title

              Safety Data Sheet (SDS) 

              AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem Certificates of Analysis

              TitleLot Number
              171260

              References

              Přehled odkazů
              Hao, J., et al. 2010. ACS Chem.Biol. 5, 245.
              Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
              Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
              Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
              Inoki, K., et al. 2003. Cell 115, 577.
              Fryer, L.G., 2002. FEBS Lett. 531, 189.
              Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
              Data Sheet

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision22-March-2012 JSW
              Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
              DescriptionA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
              FormLight yellow solid
              Intert gas (Yes/No) Packaged under inert gas
              CAS number866405-64-3
              Chemical formulaC₂₄H₂₅N₅O
              Structure formulaStructure formula
              Purity≥95% by HPLC
              SolubilityDMSO (4 mg/ml), 2% HCl (10 mg/ml), 2% Acetic Acid (10 mg/ml), or Methanol (3 mg/ml)
              Storage +2°C to +8°C
              Protect from light
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
              Toxicity Standard Handling
              ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
              Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
              Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
              Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
              Inoki, K., et al. 2003. Cell 115, 577.
              Fryer, L.G., 2002. FEBS Lett. 531, 189.
              Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.